1. Home
  2. LABT vs AUUD Comparison

LABT vs AUUD Comparison

Compare LABT & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$2.56

Market Cap

4.6M

Sector

Health Care

ML Signal

N/A

Logo Auddia Inc.

AUUD

Auddia Inc.

HOLD

Current Price

$1.33

Market Cap

4.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LABT
AUUD
Founded
N/A
2012
Country
United States
United States
Employees
N/A
5
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
4.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LABT
AUUD
Price
$2.56
$1.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
276.0K
302.6K
Earning Date
N/A
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$0.51
52 Week High
$4.72
$10.10

Technical Indicators

Market Signals
Indicator
LABT
AUUD
Relative Strength Index (RSI) 31.54 46.38
Support Level $2.10 $1.15
Resistance Level N/A $1.46
Average True Range (ATR) 0.61 0.09
MACD -0.10 0.02
Stochastic Oscillator 19.85 49.88

Price Performance

Historical Comparison
LABT
AUUD

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

About AUUD Auddia Inc.

Auddia Inc is a United States-based company. It operates through its proprietary AI platform for audio and is reinventing not only how consumers engage with AM/FM radio, podcasts, and other audio content but also how artists and labels promote their music and gain access to mainstream radio audiences. The group Discovr Radio is the first music-promotion platform to deliver artists guaranteed exposure to radio listeners. Its flagship audio superapp, called faidr, delivers multiple industry firsts, including: Ad-free listening on any AM/FM radio station, Content skipping across any AM/FM station, One-touch skipping of entire podcast ad breaks, and Integrated artist discovery experiences.

Share on Social Networks: